Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables Refunds
Ratios

Keros Therapeutics (KROS) Receivables - Other (2019 - 2021)

Keros Therapeutics (KROS) has disclosed Receivables - Other for 3 consecutive years, with $100000.0 as the latest value for Q2 2021.

  • For the quarter ending Q2 2021, Receivables - Other changed N/A year-over-year to $100000.0, compared with a TTM value of $100000.0 through Jun 2021, changed N/A, and an annual FY2019 reading of $900000.0, changed N/A over the prior year.
  • Receivables - Other was $100000.0 for Q2 2021 at Keros Therapeutics, down from $805000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $900000.0 in Q4 2019 and bottomed at $100000.0 in Q2 2021.
  • Average Receivables - Other over 3 years is $601666.7, with a median of $805000.0 recorded in 2020.